Can you compare the dry eye relief provided by Restasis versus Xiidra for someone who has tried over-the-counter drops without any lasting success?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Can you compare the dry eye relief provided by Restasis versus Xiidra for someone who has tried over-the-counter drops without any lasting success?
3 real searches · 1 real-search pass
Restasis cyclosporine ophthalmic prescribing information onset dry eye clinical trials 6 months FDA labelGoogle ↗
OBSERVED
Xiidra lifitegrast prescribing information onset 2 weeks dry eye FDA label adverse reactionsGoogle ↗
OBSERVED
Restasis versus Xiidra head to head comparative efficacy dry eye evidence no head to headGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
Restasis cyclosporine ophthalmic prescribing information onset dry eye clinical trials 6 months FDA label Google ↗
Xiidra lifitegrast prescribing information onset 2 weeks dry eye FDA label adverse reactions Google ↗
Restasis versus Xiidra head to head comparative efficacy dry eye evidence no head to head Google ↗
- DailyMed · dailymed.nlm.nih.gov
- HIGHLIGHTS OF PRESCRIBING INFORMATION · xiidra.com
- Meeting & Recommendations of the DoD P&T Committee Meeting May 3-4, 2023 · health.mil
- These highlights do not include all the information needed to use RESTASIS 0.05% safely and effectively. See full prescribing information for RESTASIS . RESTASIS ® ( cyclosporine ophthalmic emulsion ) 0.05% For topical ophthalmic use Initial U.S. Approval: 1983 · dailymed.nlm.nih.gov
- MINUTES AND RECOMMENDATIONS, February 2018 · health.mil
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
Restasis cyclosporine ophthalmic prescribing information onset dry eye clinical trials 6 months FDA label OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
Xiidra lifitegrast prescribing information onset 2 weeks dry eye FDA label adverse reactions OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
Restasis versus Xiidra head to head comparative efficacy dry eye evidence no head to head OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |